LANCE BERBERIAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LANCE BERBERIAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LANCE BERBERIAN. LANCE BERBERIAN is EVP, CIO & CTO in LABORATORY CORP OF AMERICA HOLDINGS ($LH) and SVP, Chief Information Officer in LABORATORY CORP OF AMERICA HOLDINGS ($LH).
Latest Insider Trading Transactions of LANCE BERBERIAN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 30 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Payment of Exercise | F | 251.58 | 1,079 | 271,455 | 14,186 | 15.3 K to 14.2 K (-7.07 %) |
Mar 30 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Grant | A | 0.00 | 2,413 | 0 | 15,265 | 12.9 K to 15.3 K (+18.78 %) |
Feb 17 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Option Exercise | M | 0.00 | 353 | 0 | 4,345 | |
Feb 17 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Option Exercise | M | 0.00 | 2,353 | 0 | 4,698 | |
Feb 17 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Option Exercise | M | 0.00 | 234 | 0 | 7,051 | |
Feb 17 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Payment of Exercise | F | 238.26 | 105 | 25,017 | 12,852 | 13 K to 12.9 K (-0.81 %) |
Feb 17 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Buy | M | 0.00 | 353 | 0 | 12,957 | 12.6 K to 13 K (+2.80 %) |
Feb 17 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Payment of Exercise | F | 238.26 | 699 | 166,544 | 12,604 | 13.3 K to 12.6 K (-5.25 %) |
Feb 17 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Buy | M | 0.00 | 2,353 | 0 | 13,303 | 11 K to 13.3 K (+21.49 %) |
Feb 17 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Payment of Exercise | F | 238.26 | 69 | 16,440 | 10,950 | 11 K to 11 K (-0.63 %) |
Feb 17 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Buy | M | 0.00 | 234 | 0 | 11,019 | 10.8 K to 11 K (+2.17 %) |
Feb 08 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Option Exercise | M | 0.00 | 373 | 0 | 7,285 | |
Feb 08 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Payment of Exercise | F | 223.78 | 131 | 29,315 | 10,785 | 10.9 K to 10.8 K (-1.20 %) |
Feb 08 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Buy | M | 0.00 | 373 | 0 | 10,916 | 10.5 K to 10.9 K (+3.54 %) |
Feb 04 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Option Exercise | A | 233.39 | 3,100 | 723,509 | 3,100 | |
Feb 04 2021 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Option Exercise | A | 0.00 | 890 | 0 | 7,658 | |
Apr 01 2020 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Payment of Exercise | F | 131.95 | 1,695 | 223,655 | 10,543 | 12.2 K to 10.5 K (-13.85 %) |
Apr 01 2020 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | EVP, CIO & CTO | Grant | A | 0.00 | 3,880 | 0 | 12,238 | 8.4 K to 12.2 K (+46.42 %) |
Feb 14 2020 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 353 | 0 | 6,768 | |
Feb 14 2020 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 2,353 | 0 | 7,121 | |
Feb 14 2020 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 233 | 0 | 9,474 | |
Feb 14 2020 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 187.51 | 105 | 19,689 | 8,358 | 8.5 K to 8.4 K (-1.24 %) |
Feb 14 2020 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 353 | 0 | 8,463 | 8.1 K to 8.5 K (+4.35 %) |
Feb 14 2020 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 187.51 | 699 | 131,069 | 8,110 | 8.8 K to 8.1 K (-7.94 %) |
Feb 14 2020 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 2,353 | 0 | 8,809 | 6.5 K to 8.8 K (+36.45 %) |
Feb 14 2020 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 187.51 | 68 | 12,751 | 6,456 | 6.5 K to 6.5 K (-1.04 %) |
Feb 14 2020 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 233 | 0 | 6,524 | 6.3 K to 6.5 K (+3.70 %) |
Feb 11 2020 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 297 | 0 | 9,707 | |
Feb 11 2020 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 182.33 | 103 | 18,780 | 6,291 | 6.4 K to 6.3 K (-1.61 %) |
Feb 11 2020 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 297 | 0 | 6,394 | 6.1 K to 6.4 K (+4.87 %) |
Feb 06 2020 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | A | 182.51 | 4,900 | 894,299 | 4,900 | |
Feb 06 2020 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | A | 0.00 | 1,120 | 0 | 10,004 | |
Sep 04 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Sell | S | 169.80 | 5,902 | 1,002,172 | 6,097 | 12 K to 6.1 K (-49.19 %) |
Feb 13 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 3,047 | 0 | 997 | |
Feb 13 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 450 | 0 | 4,044 | |
Feb 13 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 144.29 | 905 | 130,582 | 8,593 | 9.5 K to 8.6 K (-9.53 %) |
Feb 13 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 3,047 | 0 | 9,498 | 6.5 K to 9.5 K (+47.23 %) |
Feb 13 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 144.29 | 132 | 19,046 | 6,451 | 6.6 K to 6.5 K (-2.01 %) |
Feb 13 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 450 | 0 | 6,583 | 6.1 K to 6.6 K (+7.34 %) |
Feb 11 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 297 | 0 | 4,494 | |
Feb 11 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 147.46 | 104 | 15,336 | 6,133 | 6.2 K to 6.1 K (-1.67 %) |
Feb 11 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 297 | 0 | 6,237 | 5.9 K to 6.2 K (+5.00 %) |
Jun 04 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Sell | S | 182.37 | 315 | 57,447 | 5,940 | 6.3 K to 5.9 K (-5.04 %) |
Jun 04 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Sell | S | 182.30 | 5,185 | 945,226 | 6,255 | 11.4 K to 6.3 K (-45.32 %) |
Apr 02 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 161.75 | 2,121 | 343,072 | 11,440 | 13.6 K to 11.4 K (-15.64 %) |
Apr 02 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Grant | A | 0.00 | 4,852 | 0 | 13,561 | 8.7 K to 13.6 K (+55.71 %) |
Mar 14 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 400 | 0 | 4,791 | |
Mar 14 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 175.61 | 120 | 21,073 | 8,709 | 8.8 K to 8.7 K (-1.36 %) |
Mar 14 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 400 | 0 | 8,829 | 8.4 K to 8.8 K (+4.75 %) |
Feb 14 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | A | 0.00 | 700 | 0 | 5,191 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | A | 168.49 | 2,700 | 454,923 | 2,700 | |
Feb 13 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 3,047 | 0 | 4,491 | |
Feb 13 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 450 | 0 | 7,538 | |
Feb 13 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 168.08 | 913 | 153,457 | 8,429 | 9.3 K to 8.4 K (-9.77 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 3,047 | 0 | 9,342 | 6.3 K to 9.3 K (+48.40 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 168.08 | 135 | 22,691 | 6,295 | 6.4 K to 6.3 K (-2.10 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 450 | 0 | 6,430 | 6 K to 6.4 K (+7.53 %) |
Feb 09 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 296 | 0 | 7,988 | |
Feb 09 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 169.66 | 105 | 17,814 | 5,980 | 6.1 K to 6 K (-1.73 %) |
Feb 09 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 296 | 0 | 6,085 | 5.8 K to 6.1 K (+5.11 %) |
May 24 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Sell | S | 139.85 | 3,613 | 505,259 | 5,789 | 9.4 K to 5.8 K (-38.43 %) |
Mar 31 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 143.19 | 3,142 | 449,903 | 9,402 | 12.5 K to 9.4 K (-25.05 %) |
Mar 31 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Grant | A | 0.00 | 6,755 | 0 | 12,544 | 5.8 K to 12.5 K (+116.69 %) |
Mar 14 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 400 | 0 | 8,284 | |
Mar 14 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 144.24 | 132 | 19,040 | 5,789 | 5.9 K to 5.8 K (-2.23 %) |
Mar 14 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 400 | 0 | 5,921 | 5.5 K to 5.9 K (+7.25 %) |
Feb 13 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 3,046 | 0 | 10,164 | |
Feb 13 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 450 | 0 | 13,210 | |
Feb 13 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 133.83 | 999 | 133,696 | 4,530 | 5.5 K to 4.5 K (-18.07 %) |
Feb 13 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 3,046 | 0 | 5,529 | 2.5 K to 5.5 K (+122.67 %) |
Feb 13 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 133.83 | 172 | 23,019 | 2,483 | 2.7 K to 2.5 K (-6.48 %) |
Feb 13 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 450 | 0 | 2,655 | 2.2 K to 2.7 K (+20.41 %) |
Feb 09 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | A | 130.60 | 3,400 | 444,040 | 3,400 | |
Feb 09 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | A | 0.00 | 890 | 0 | 13,660 | |
Mar 15 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 400 | 0 | 12,770 | |
Mar 15 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 115.49 | 133 | 15,360 | 2,205 | 2.3 K to 2.2 K (-5.69 %) |
Mar 15 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 400 | 0 | 2,338 | 1.9 K to 2.3 K (+20.64 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 550 | 0 | 13,170 | |
Feb 16 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 930 | 0 | 13,720 | |
Feb 16 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 101.40 | 179 | 18,151 | 1,938 | 2.1 K to 1.9 K (-8.46 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 550 | 0 | 2,117 | 1.6 K to 2.1 K (+35.10 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 101.40 | 334 | 33,868 | 1,567 | 1.9 K to 1.6 K (-17.57 %) |
Feb 16 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 930 | 0 | 1,901 | 971 to 1.9 K (+95.78 %) |
Feb 11 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | A | 0.00 | 9,140 | 0 | 14,650 | |
Feb 11 2016 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | A | 0.00 | 1,350 | 0 | 5,510 | |
Mar 13 2015 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | A | 0.00 | 1,200 | 0 | 4,160 |
Page: 1